C07D 245/02
Not condensed with other rings
Official title: not condensed with other rings
C07D245/02 (Not condensed with other rings) appears on 93 US grants and 64 published applications in this corpus.
Search patents in C07D- Granted patents
- 93
- Published applications
- 64
- Assignees
- 79
- Inventors
- 301
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 5 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 3 |
| 2006 | 0 | 0 |
| 2007 | 3 | 2 |
| 2008 | 1 | 0 |
| 2009 | 4 | 3 |
| 2010 | 0 | 5 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 2 | 3 |
| 2014 | 1 | 4 |
| 2015 | 3 | 5 |
| 2016 | 5 | 5 |
| 2017 | 6 | 3 |
| 2018 | 1 | 0 |
| 2019 | 0 | 3 |
| 2020 | 3 | 4 |
| 2021 | 3 | 5 |
| 2022 | 0 | 5 |
| 2023 | 6 | 2 |
| 2024 | 1 | 2 |
| 2025 | 3 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Macrocyclic compounds as proteasome inhibitors18 Nov 2025US 12,473,331 B2Cornell University
- Marking precursor with squaric acid coupling12 Aug 2025US 12,383,636 B2Telix Pharmaceuticals Limited
- 1,4-diazocane compound or salt thereof29 Apr 2025US 12,286,417 B2D. Western Therapeutics Institute, Inc.
- Thioester cationic lipids3 Sep 2024US 12,076,439 B2Translate Bio, Inc.
- Labeling precursors with squaric acid coupling5 Dec 2023US 11,833,229 B2SCV Spezial-Chemikalien-Vertriebs GmbH
- Novel equilibrative nucleoside transporter inhibitors and methods of making and using same12 Mar 2026US 2026/0069604 A1
- Labeling precursors with squaric acid coupling18 Sep 2025US 2025/0288702 A1Telix Pharmaceuticals Limited
- Syrbactin macrolactams and unnatural analogs as proteasome inhibitors for the treatment of multiple myeloma and chemoenzymatic synthesis thereof11 Sep 2025US 2025/0282818 A1University of Florida Research Foundation, Inc.
- Thioester cationic lipids27 Mar 2025US 2025/0099384 A1Translate Bio, Inc.
- Compounds and methods for treating corona viruses23 Jan 2025US 2025/0025443 A1Clear Creek Bio, Inc.
Most cited
By later US patents
- Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors60US 5,811,422 AThe DuPont Merck Pharmaceutical Company · 1998
- Macrocyclic oxamides36US 5,298,618 ATexaco Chemical Company · 1994
- Chelating agents for forming complexes with radioactive isotopes, metal complexes thereof and use thereof in diagnosis and therapy28US 5,302,370 AInstitut fur Diagnostikforschung GmbH · 1994
- Preparation of acrylates and methacrylates25US 4,777,265 ABASF SE · 1988
- Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors24US 5,610,294 AThe Du Pont Merck Pharmaceutical Company · 1997